Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000120

EVP, Chief Reg. & Quality Off. sold 260 shares at $486.35 ($126,451)

  • EVP, Chief Reg. & Quality Off. gave up 1,627 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −1,627 $485.11 $789,274 47,023 D
2026-02-25 Sale : show line 2 in the form 10b5-1 −260 $486.35 $126,451 46,763 D
Open-market sales · 260 sh · avg $486.35 · $126,451
Loading xslF345X05/wk-form4_1772150109.xml…